Sigma-Aldrich and Merck KGaA have EU approval for acquisition
The EC provided conditional approval of the acquisition on June 15, 2015, subject to approval of the divestment of certain Sigma-Aldrich assets. On October 20, 2015, Sigma-Aldrich announced an agreement to sell parts of its solvents and inorganics business to Honeywell.
The EC has now approved Honeywell as a suitable buyer of the divestment business meaning all closing requirements have been met and the formal completion of the Sigma-Aldrich acquisition will take place on November 18.
On September 22, 2014, Merck and Sigma-Aldrich announced they had entered into a definitive agreement under which Merck will acquire Sigma-Aldrich for $17 billion - $140 cash per share - establishing one of the leading players in the $130 billion global life science industry. ■